Skip to main content

GoodRx Holdings, Inc. (GDRX) Stock Forecast 2025 - AI Price Prediction & Analysis


GoodRx Holdings, Inc. (GDRX) AI Stock Price Forecast & Investment Analysis

GoodRx Holdings, Inc. Stock Price Chart and Technical Analysis

Loading GoodRx Holdings, Inc. interactive price chart and technical analysis...

GoodRx Holdings, Inc. (GDRX) - Comprehensive Stock Analysis & Investment Research

Deep dive into GoodRx Holdings, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about GoodRx Holdings, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For GoodRx Holdings, Inc.: GoodRx Holdings, Inc. operates in the Technology sector, making it an emerging small-cap investment.

GoodRx Holdings, Inc. (Stock Symbol: GDRX) is a leading company in the Technology sector , specifically operating within the Services-Computer Processing & Data Preparation industry.

The organization employs approximately 893 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing GoodRx Holdings, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GoodRx Holdings, Inc.: With $799M in annual revenue and 0.1% net margin, the company demonstrates developing profitability.

Annual Revenue: $799 million generating a 0.1% net profit margin .

Market Capitalization: $1580 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -1.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for GoodRx Holdings, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For GoodRx Holdings, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for GoodRx Holdings, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: GoodRx Holdings, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For GoodRx Holdings, Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

GoodRx Holdings, Inc. strategically competes in the highly dynamic Services-Computer Processing & Data Preparation marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company demonstrates robust operational efficiency through strong free cash flow generation of $126 million annually, complemented by impressive 57.7% year-over-year cash flow growth.

The company maintains a healthy 41.4% gross margin, indicating strong pricing power and operational efficiency.

GoodRx Holdings, Inc. (GDRX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for GoodRx Holdings, Inc. stock analysis.

Loading GoodRx Holdings, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into GoodRx Holdings, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if GoodRx Holdings, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For GoodRx Holdings, Inc.: With a P/E ratio of 45.67, the market highly values future growth prospects.

P/E Ratio 45.67x
P/B Ratio 2.46x
Market Cap $1580M
EPS $0.09
Book Value/Share $1.75
Revenue/Share $2.17
FCF/Share $0.27
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently GoodRx Holdings, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GoodRx Holdings, Inc.: An ROE of -1.9% indicates room for improvement in shareholder value creation.

ROE -1.9%
ROA -1.0%
ROIC 0.0%
Gross Margin 41.4%
Operating Margin -2.6%
Net Margin 0.1%
EBT Margin 1.9%
Tax Rate 199.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess GoodRx Holdings, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For GoodRx Holdings, Inc.: A current ratio of 16.76 indicates strong liquidity.

Current Ratio 16.76x
Quick Ratio 16.42x
D/E Ratio 0.87x
Financial Leverage 1.96x
Interest Coverage 1.6x
Working Capital $1027M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal GoodRx Holdings, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For GoodRx Holdings, Inc.: Free cash flow of $126M provides flexibility for shareholder returns and growth investments.

Operating Cash Flow $163M
Free Cash Flow $126M
Capital Spending $-37M
OCF Growth YoY 57.7%
FCF Growth YoY 23.2%
FCF/Sales 16.0%
CapEx/Sales 4.7%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively GoodRx Holdings, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For GoodRx Holdings, Inc.: An asset turnover of 0.52x suggests room for improvement in asset utilization.

Asset Turnover 0.52x
Receivables Turnover 8.0x
Fixed Assets Turnover 15.8x
Days Sales Outstanding 46 days
Payables Period 105 days
Understanding Financial Statement Data

What these metrics mean: Key figures from GoodRx Holdings, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For GoodRx Holdings, Inc.: With annual revenue of $799M, GoodRx Holdings, Inc. demonstrates solid business size.

Income Statement ($ Millions)
Total Revenue $799M
R&D Expense $124M
SG&A Expense $67M
Cost of Goods Sold $301M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 65%
Cash & Short-term Investments 55%
Total Liabilities 49%
Short-term Debt 0%
Accounts Receivable 8%
Dividend & Shareholder Information
Shares Outstanding 368M
Growth Metrics (YoY)
EPS Growth -0.6%

Latest GoodRx Holdings, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting GoodRx Holdings, Inc. (GDRX) stock price and investment outlook.

, source: Reuters

Shares of private-equity-backed GoodRx Holdings Inc surged 40% in their debut on the Nasdaq on Wednesday after the online prescription drug platform raised $1.14 billion in its initial public offering ...

GoodRx Holdings, Inc. Competitors & Peer Analysis - Technology Sector

Comparative analysis of GoodRx Holdings, Inc. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ADP Unlock Forecast - 30 Days FREE Trial $116557M 28.6x 18.8x
ALXY Unlock Forecast - 30 Days FREE Trial $M x x
APLD Unlock Forecast - 30 Days FREE Trial $8369M -7.2x 8.0x
ATHM Unlock Forecast - 30 Days FREE Trial $14241M x 5.3x
AVAI Unlock Forecast - 30 Days FREE Trial $48M x x
BHIC Unlock Forecast - 30 Days FREE Trial $177M 186.6x 103.1x
BILI Unlock Forecast - 30 Days FREE Trial $10270M x 10.1x
BLBLF Unlock Forecast - 30 Days FREE Trial $7831M x 7.7x
BRQL Unlock Forecast - 30 Days FREE Trial $19M x 1.2x
BYOC Unlock Forecast - 30 Days FREE Trial $2M x x
CARG Unlock Forecast - 30 Days FREE Trial $3488M 23.1x 8.0x
CARS Unlock Forecast - 30 Days FREE Trial $656M 16.0x 1.4x
CHR Unlock Forecast - 30 Days FREE Trial $2M 12.5x 0.0x
CLVT Unlock Forecast - 30 Days FREE Trial $2475M -8.1x 0.5x
CSGS Unlock Forecast - 30 Days FREE Trial $1822M 23.9x 4.5x
CTKYY Unlock Forecast - 30 Days FREE Trial $67M x x
DDI Unlock Forecast - 30 Days FREE Trial $22M x 0.0x
DTST Unlock Forecast - 30 Days FREE Trial $29M 180.6x 1.3x
DXC Unlock Forecast - 30 Days FREE Trial $2595M 6.9x 0.8x
EGHT Unlock Forecast - 30 Days FREE Trial $246M -5.9x 1.9x
FA Unlock Forecast - 30 Days FREE Trial $2458M 171.7x 1.9x
FIVN Unlock Forecast - 30 Days FREE Trial $1862M 211.0x 2.6x
GDRX Unlock Forecast - 30 Days FREE Trial $1580M 45.7x 2.5x
GMHS Unlock Forecast - 30 Days FREE Trial $70M x 2.2x
HNGE Unlock Forecast - 30 Days FREE Trial $3237M x 18.6x
HNIT Unlock Forecast - 30 Days FREE Trial $445M x 55061.8x
HTCR Unlock Forecast - 30 Days FREE Trial $14M -8.2x 2.9x
IBEX Unlock Forecast - 30 Days FREE Trial $564M 15.3x 4.2x
INOD Unlock Forecast - 30 Days FREE Trial $3175M 72.7x 36.6x
JOYY Unlock Forecast - 30 Days FREE Trial $67867M x 217.7x
KWIK Unlock Forecast - 30 Days FREE Trial $10M x x
LIF Unlock Forecast - 30 Days FREE Trial $9030M 327.6x 24.6x
LIFX Unlock Forecast - 30 Days FREE Trial $2855M 103.6x 7.8x
LZ Unlock Forecast - 30 Days FREE Trial $1780M 61.9x 9.2x
NRDS Unlock Forecast - 30 Days FREE Trial $785M 16.7x 2.0x
ONEI Unlock Forecast - 30 Days FREE Trial $9M x x
ONFO Unlock Forecast - 30 Days FREE Trial $8M x 2.7x
PEGA Unlock Forecast - 30 Days FREE Trial $10429M 47.4x 16.7x
PHUN Unlock Forecast - 30 Days FREE Trial $57M -6.9x 0.6x
PLTK Unlock Forecast - 30 Days FREE Trial $1278M 14.8x -14.4x
QBTS Unlock Forecast - 30 Days FREE Trial $11918M -8.9x 17.2x
RAMP Unlock Forecast - 30 Days FREE Trial $0M 296.1x 0.0x
RDDT Unlock Forecast - 30 Days FREE Trial $42484M 196.4x 17.8x
RNG Unlock Forecast - 30 Days FREE Trial $1503M -33.3x -2.8x
SDCH Unlock Forecast - 30 Days FREE Trial $17M x 6.8x
SOHU Unlock Forecast - 30 Days FREE Trial $456M x 0.5x
SSTK Unlock Forecast - 30 Days FREE Trial $761M 11.8x 1.3x
TASK Unlock Forecast - 30 Days FREE Trial $1281M 20.4x 2.4x
TCX Unlock Forecast - 30 Days FREE Trial $201M -2.6x -2.2x
TOST Unlock Forecast - 30 Days FREE Trial $22263M 99.4x 12.3x
TRVG Unlock Forecast - 30 Days FREE Trial $1098M x 5.6x
TZUP Unlock Forecast - 30 Days FREE Trial $49M x 26.8x
ULY Unlock Forecast - 30 Days FREE Trial $4M 0.0x -0.2x
UPWK Unlock Forecast - 30 Days FREE Trial $2416M 9.9x 4.0x
VS Unlock Forecast - 30 Days FREE Trial $3M x 0.3x
VSSYW Unlock Forecast - 30 Days FREE Trial $0M x 0.0x
WNFT Unlock Forecast - 30 Days FREE Trial $3M x x
YEXT Unlock Forecast - 30 Days FREE Trial $1091M 146.6x 7.2x

Frequently Asked Questions - GoodRx Holdings, Inc. Stock Forecast

How accurate are GoodRx Holdings, Inc. stock predictions?

Our AI model demonstrates 46% historical accuracy for GDRX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence GoodRx Holdings, Inc. stock price forecasts?

Our analysis considers GoodRx Holdings, Inc.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is GoodRx Holdings, Inc. a good investment in 2025?

Based on our AI analysis, GoodRx Holdings, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are GoodRx Holdings, Inc. forecasts updated?

GoodRx Holdings, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced GoodRx Holdings, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for GoodRx Holdings, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...